Reporting owner · CIK 0001499254

Titterton Lewis H jr

Visual SEC Form 4 history across 1 companies, 8 transactions and 7 filings.

DIRAnixa Biosciences Inc
Open-market mix
Filings7Form 4 records
Buying$83.4K6 purchases
Selling$00 sales
Net value$83.4KBuys minus sells
Companies12 securities
Most recentSep 10, 2026buy

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Average return0.0%Across 1 open-market buy
Median return0.0%Half the buys outperformed this
How it's computed

For every open-market buy (Form 4 code P, acquisition A) in the selected window, we take the closing price on the transaction date and 90 calendar days later, then compute the percentage change. The figures shown are the simple average and median of those per-buy returns.

  • Window follows the rest of the summary (all-history or last 3 months).
  • Only buys with a resolved price context are counted.
  • Includes both positive and negative outcomes; gains and losses net out at the per-buy level.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-55Jan 25Jan 261Sep 26

Net value flow

Buys minus sells

Jan 25
$56.1K
Jan 26
$0
Sep 26
$27.3K

Transaction texture

Ownership and ticket size

Average P/S size$13.9K
Median P/S size$10.8K
Direct8
Indirect0
Sep 10, 2026buy

Latest Form 4 facts

Quick context from source filings

Latest transaction

buy at Anixa Biosciences Inc on Sep 10, 2026 valued at $27,300.

Review SEC filing
Latest buy

buy at Anixa Biosciences Inc on Sep 10, 2026 valued at $27,300.

Review SEC filing
Latest sale

No open-market insider sale is available.

Associated companies

Visual map of known reporting history

Latest insider transactions

Form 4 filings from available history. Click any column to sort; click it again to flip the order.

Titterton Lewis H jr transactions
IDTickerInsiderRoleTypeSharesValueCodeFiledTrans date
#210468ANIXTitterton Lewis H jr
DIR
buy10.0k$2.73MP09/1409/10
#106006ANIXTitterton Lewis H jr
DIR
grant25.0k$0A01/0701/05
#50922ANIXTitterton Lewis H jr
DIR
buy1.00k$300kP01/27/202501/24/2025
#50920ANIXTitterton Lewis H jr
DIR
buy2.00k$582kP01/27/202501/23/2025
#44833ANIXTitterton Lewis H jr
DIR
buy2.00k$602kP01/23/202501/22/2025
#41122ANIXTitterton Lewis H jr
DIR
buy6.00k$1.55MP01/22/202501/21/2025
#115705ANIXTitterton Lewis H jr
DIR
buy10.0k$2.57MP01/17/202501/17/2025
#14802ANIXTitterton Lewis H jr
DIR
grant25.0k$0A01/03/202501/02/2025

Titterton Lewis H jr Insider Activity FAQ

SEC Form 4 context

Who is Titterton Lewis H jr?

Titterton Lewis H jr is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001499254.

Which companies has Titterton Lewis H jr reported transactions for?

Anixa Biosciences Inc

When was Titterton Lewis H jr's latest insider buy?

buy at Anixa Biosciences Inc on Sep 10, 2026 valued at $27,300.

When was Titterton Lewis H jr's latest insider sale?

No open-market insider sale is available for this period.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.